2. Introduction
Recombinant DNA Technology (also Know as
Genetic Engineering) is the set of
techniques that involves the identification,
isolation and insertion of Gene of interest in
to a vector to form a recombinant DNA
molecule and production of large quantities'
of that gene fragment or product encoded
by that gene.
3. History
Paul Berg, Herbert W. Boyer and stanly N. Cohen were
the pioneer in the field of Recombinant DNA Technology
but other Scientis also made important contributions as
well.
In 1970 Werner Arber and Hamilton O discovered
Restriction enzymes.
In 1972,Paulberg developed the First Recombinant DNA
molecule that combine DNA from SV40 virus and lambda
page.
1973, Together with Stanley Cohen, Boyer demonstrated
the possibility of producing recombinant DNA in
bacteria.
4. Steps in rDNA technology
Step 1: Identification & Isolation of Genes of Interest or
DNA fragments to be cloned.
Step 2:Instertion of isolated genes in a suitable Vector.
Step 3: Introduction of this vector in to suitable
organism/ cell called host ( Transformation).
Step 4: Selection of transformed host cell.
Step 5: Multiplication or expression of the introduced
gene in the host cell.
6. Identification & Isolation of Gene of
Interest
From where we get this gene of intrest?
Genomic Library
cDNA Library
Chemical synthesis of gene if we
know the sequence
If the no of copies of the desired
gene is not enough for gene cloning
we can opt for gene amplification
technique like PCR
7. Enzymes for DNA manipulation
Template –dependent DNA polymerase :
DNA Polymerases I
Taq DNA Polymerase
Reverse Transcriptase
Nucleases
Mugbean nuclease
S1Nuclease
Rnase A
Rnase H
Restriction Endonuclease
Type I
Type II
Type III
Type IIs
End-modification Enztymes
Terminal deoxynucleotidyl tansferease
Alkaline phosphatase
T4 poly nucleotudw kinase
Ligases
8. Vectors: The DNA molecules that as transporting vehicle
which carries foreign DNA into a host cell for the purpose of
cloning and expression
Important Properties of a Vector:
Ability to replicate on host cells
MCS (multiple cloning sites) with unique restriction sites.
Genetic Marker to select host cells containing Recombinant DNA.
Low molecular weight.
Vectors for E.Coli: Plasmid vectors (pBR 322, pUC 19 etc)
Viral DNA based Vectors Cosmid s
Vectors for Yeast: YEp, YIp, YRp, YCp, YAC
Vectors for Animals: P element for insects, Viral DNA based
vectors
Vectors for plant: Plasmid Based & Viral vectors
9. Maximum DNA insert possible
with different cloning vectors
Vector Host Insert Size
M13 E. Coli 1-4 kb
Plasmid E. Coli 1-5 kb
Lambda Phase E. Coli 5-25 kb
Cosmids E. Coli 35-45 kb
P1 phase E. Coli 70-100 kb
PACs E. Coli 100-300 kb
BACs E. Coli <300 kb
YACs S. Cerevisiae 200-2000 kb
Source: Principle of Gene manipulation by S. B. Primrose
10. Gene Transformation Methods
There are multiple ways to deliberately introduce
foreign DNA or RNA into bacteria or eukaryotic cells
in molecular biology and scientific research.
Transformation
Transduction
Conjugation
Transfection
Chemical methods (Cacl2 Mediated, PEG Mediated,
Calcium Phosphate, Liposome and Lipofection,
Protoplast Fusion, Receptor Mediated)
Physical methods (Liposome encapsulation,
Microinjection, Particle bombardment,
Electroporation)
11. Selection of Transformed
Cells
Genetic selection of transformed or transfected cells is
a significant step of Recombinant DNA technology and is
achieved by two ways:
Selectable Markers: Gene encode a product that allows
the artificial selections of transformed cells.
Positive selectable marker genes
Negative Marker Genes
Scorable/ screenable markers: also called as visual
marker, gene, generate a product that can be detected
using a simple and often quantitative assay
12. Expression Vectors and Expression
Systems
The vectors designed for production of a protein
specified by the DNA insert is an Expression Vector
A system in which a cloned gene can be expressed is an
expression system
Prokaryotic (E. coli, Bacillus subtilis, Staphylococcus
carnosus, Streptomyces lividans)
Eukaryotic (Yeast, Aspergillus niger, Baculovirus-Insect
Cells, Mammalian Cells (e.g. Chinese Hamster Ovary cells)
14. Applications of Recombinant DNA
technology
Source: Khan, Suliman, et al. ." International journal of genomics (2016).
15. Limitations of Recombinant
DNA technology
•Destruction of native species in the environment the genetically
modified species are introduced in.
•Resilient plants can theoretically give rise to resilient weeds which
can be difficult to control.
•Cross contamination and migration of proprietary DNA between
organisms.
•Recombinant organisms contaminating the natural environment.
•Creation of superbug is hypothesized.
•Ethical concern about humans trying to play God and mess with
the nature’s way of selection. It is exaggerated by the fear of
unknown of what all can be created using the technology and how
is it going to impact the civilization.
•Such a system might lead to people having their genetic
information stolen and used without permission.
•Many people worry about the safety of modifying food and
medicines using recombinant DNA technology.
16. Safety and Environmental
Issues
The concern is that the food produced by genetic
engineering could contain toxic proteins or substances that
can cause allergies in people who consume them.
Genetically engineered crops could spread into the wild
and wipe out native plant species.
Transgenic crops could transmit their new genes to other
species in neighboring areas.
Example: super-weeds produced by rice and lawn grasses
exchanging pollen with native species
Foods produced by transgenic crops can be sold without
special permits or labels if the product is identical to
products produced by non-transgenic crops.
Example: corn, tomatoes
17. Advancement to Recombinant DNA
Technology:-Genome editing
Altering the sequence of DNA “in situ”
Targeted mutagenesis
Knock-outs
Point mutations
Gene insertions or “trait landing pads”
Ideally leaving no transgene footprint
18. Genome editing tools
Meganucleases: 1990s
Oligonucleotide-directed mutagenesis:
late 1990s
Zinc finger nucleases (ZFNs): mid 2000s
Transcription activator like effector
nucleases (TALENs): early 2010s
Clustered regularly spaced short
palindromic repeats (CRISPR): 2013
19. Way forward
Technological innovations will continue
Until disaster strikes
And then innovations will resume
But they will be (more) regulated
So there is a balance between
innovation potential risks and
regulation ensure safety
20. Trends
Life science/ Biotechnology synthetic biology
Designed components
More precise gene integration and regulation
Building a crop from scratch?
Transgenics genome editing
Regulations? What about a tiered approach?
Increasing gap between public’s knowledge of science and technology
and science and technology advances
But…patents expire and economics shift…times change